InvestorsObserver
×
News Home

Is Brooklyn Immunotherapeutics Inc (BTX) Stock a Smart Investment Wednesday?

Wednesday, July 13, 2022 11:25 AM | InvestorsObserver Analysts

Mentioned in this article

Is Brooklyn Immunotherapeutics Inc (BTX) Stock a Smart Investment Wednesday?

Brooklyn Immunotherapeutics Inc (BTX) stock is down -94.90% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BTX stock a score of 25 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 3. BTX's rank also includes a long-term technical score of 6.
Overall Score - 25
BTX has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on BTX!

What's Happening with BTX Stock Today

Brooklyn Immunotherapeutics Inc (BTX) stock is down -4.57% while the S&P 500 is down -0.13% as of 11:23 AM on Wednesday, Jul 13. BTX is down -$0.03 from the previous closing price of $0.64 on volume of 161,888 shares. Over the past year the S&P 500 is down -12.71% while BTX is down -94.90%. BTX lost -$2.28 per share in the over the last 12 months. Click Here to get the full Stock Report for Brooklyn Immunotherapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App